Emerging therapeutic alternatives for snakebite envenoming
Guardado en:
| 作者: | |
|---|---|
| 格式: | contribución de congreso |
| Fecha de Publicación: | 2019 |
| 實物特徵: | The primary treatment for snakebite envenoming remains the administration of animal-derived antivenoms. While highly effective against systemic manifestations, antivenoms present drawbacks, including the need for trained healthcare staff, limited specificity (being restricted to the venoms used in immunization), and the risk of adverse reactions. |
| País: | Kérwá |
| 機構: | Universidad de Costa Rica |
| Repositorio: | Kérwá |
| 語言: | Inglés |
| OAI Identifier: | oai:kerwa.ucr.ac.cr:10669/104658 |
| 在線閱讀: | https://hdl.handle.net/10669/104658 https://doi.org/10.1016/j.toxicon.2019.06.044 |
| Palabra clave: | Snakebite envenoming Antivenoms Recombinant antibodies Toxin inhibitors Phospholipases A2 Metalloproteinases Nanoparticles |